Alpha-melanocyte stimulating hormone analogues: the perils and the promise.
Mazza
Joni M
JM
Weill Cornell Medical College, New York-Presbyterian Hospital-Weill Cornell Medical Center, USA.
Zippin
Jonathan H
JH
D000818:Animals; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008543:Melanins / Q000378:metabolism*; D046351:Protoporphyria, Erythropoietic / Q000188:drug therapy* / Q000503:physiopathology; D012867:Skin / Q000187:drug effects / Q000378:metabolism; D012871:Skin Diseases / Q000188:drug therapy / Q000503:physiopathology; D012880:Skin Pigmentation / Q000187:drug effects; D000521:alpha-MSH / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D008543:Melanins; D000521:alpha-MSH; C534526:afamelanotide